Erythropoietin for the treatment of anemia in patients with hematologic disorders
This article introduces common data and our experience concerning the treatment with recombinant human erythropoietin anemia (r-HuEPO) in anemic patients with different disorders. We cited as an example some results of Eprex (Janssen-Cilag) therapy for patients with hematologic disorders in Russia....
Saved in:
Main Authors: | R. A. Podgurskaya, V. V. Pshibieva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2022-11-01
|
Series: | Онкогематология |
Subjects: | |
Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/642 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Eprex in the management of anemia related to lymphoproliferative disorders
by: P. N. Barlamov, et al.
Published: (2022-11-01) -
Detection of antibodies to erythropoietin-based drugs: is it possible to create the universal test system?
by: A. M. Kudryashova, et al.
Published: (2021-06-01) -
Recombinant erythropoietin in the treatment of anemia in cancer patients
by: S. V. Vorobiova, et al.
Published: (2022-11-01) -
Study the levels of Erythropoietin, Glutathione and Malondialdehyde in women with gestational anemia
by: Aaraf Sabah Abdulwaheed, et al.
Published: (2023-02-01) -
Cohort Prospective Study to Evaluate Immunogenicity of Epodion® (Biosimilar Epoetin-α) in Anemia Associated with Chronic Kidney Disease (CKD) Patients
by: Nova Angginy, et al.
Published: (2022-09-01)